BMO Capital lowered the firm’s price target on Marsh McLennan (MMC) to $208 from $222 and keeps a Market Perform rating on the shares, admitting that while the large move in shares “feels overdone,” the firm would make the case that the stock “screens as potentially not inexpensive” in the context of the current macro/pricing environment and the company’s organic growth underperformance. The firm, which believes the valuation “may not be as attractive following Thursday’s sell-off,” views the stock as unlikely to work unless the company communicates a better growth profile or uncertainty increases around the market’s earnings power.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MMC:
- Marsh McLennan price target lowered to $195 from $215 at Morgan Stanley
- Marsh McLennan price target lowered to $237 from $243 at Evercore ISI
- Marsh & McLennan Companies: Hold Rating Reaffirmed Amid Operational Challenges and Macroeconomic Uncertainties
- Marsh McLennan price target lowered to $212 from $222 at Wells Fargo
- Marsh McLennan upgraded to Market Perform from Underperform at Keefe Bruyette
